H4P
  • Home
  • Who we are
    • Our Team
    • Collaborators
    • Funders
  • What we do
    • Data Sources
    • Projects
    • Publications
    • Courses & Conferences
    • Literature Search
  • Resources
    • Analytic Tools
    • Useful links
    • Code Lists
  • Contact
  • Careers

Funders

Our research projects are funded by the following federal agencies:

Picture

R01  In-utero exposure to psychotropic medications and the risk of neurodevelopmental disorder, 2018-2023, NIMH

Picture

​R01 Safety of Benzodiazepines and Non-Benzodiazepine Sedative Hypnotics in Pregnancy, 2022-2027, NICHD
​R01 TreeScan to Evaluate the Safety of New Drugs in Pediatric Populations, 2022-2027, NICHD
R01 
Active Surveillance of the Safety of Antipsychotic Medications in Pregnancy, 2021-2026, NICHD
R01 
Comparative Safety of Non-Insulin Agents in Pregnant Women with Pregestational Diabetes, 2019-2024, NICHD

Picture

R01 The Comparative Effectiveness and Safety of Pharmacotherapies for the Treatment of Opioid Use Disorder in Pregnancy 2020-2023, NIDA

We also conduct research sponsored by industry partners (e.g., Eli Lilly, GlaxoSmithKline).

Past Research Projects
Picture
K01  Improved methods to assess the comparative safety of new psychiatric medications, 2013-2018, NIMH
​R01 
Comparative safety of commonly prescribed psychotropic drugs in pregnant women, 2014-2017, NIMH
Picture

​R03 Ondansetron and risk of congenital malformations, 2017-2019, NICHD
K08 
Comparative safety and effectiveness of antihypertensives in pregnancy, 2013-2018, NICHD
​R21 
Pregnancy registries nested in the international pooled health care databases, 2017-2019, NICHD
​R21 International Pooling Project to Study the Safety of Drugs in Pregnancy, 2017-2019, NICHD
Picture
R01 The impact of prescription opioid use on pregnancy outcomes, 2017-2021, NIDA
Picture
R01 Comparative effectiveness and safety of depression treatments during pregnancy, 2009-2014, AHRQ
Picture
Developing the capability of using national Medicaid data for FDA post-marketing surveillance to assess medication safety during pregnancy, 2017-2019, FDA
Picture
H4P is a program of Harvard T.H. Chan School of Public Health and the Division of Phamacoepidemiology & Pharmacoeconomics 
Department of Medicine at Brigham & Women's Hospital and Harvard Medical School
1620 Tremont Street Suite 3030 | Boston, MA 02120 | 617-278-0930​ | h4p@bwh.harvard.edu
Picture
Picture
  • Home
  • Who we are
    • Our Team
    • Collaborators
    • Funders
  • What we do
    • Data Sources
    • Projects
    • Publications
    • Courses & Conferences
    • Literature Search
  • Resources
    • Analytic Tools
    • Useful links
    • Code Lists
  • Contact
  • Careers